Download presentation
Published byKaren Erica Gibson Modified over 8 years ago
1
Factor Assays Robert Gosselin MT (ASCP), CLS
2
Most labs: Clot based: Modified PT or aPTT PT based: usually II, V, VII, X aPTT based: usually VIII, IX, XI, XII Chromogenic Antigenic - ELISA
3
Coagulation Testing in the Clinical Laboratory
Prothrombin times (PT) PP Plasma Activator (+ CaCl2) Clot Detection 37oC Activated partial thromboplastin times (aPTT) PP Plasma Activators CaCl Clot Detection Optical methods: change in turbidity Mechnical methods: change in motion
4
Coagulation Testing in the Clinical Laboratory
Factor VIII assay: clot based Dil PP Plasma Factor VIII deficient plasma Activators Clot detection CaCl2 37oC
5
Factor Activity assays
Calibrator of known value (e.g. Factor VIII 95%) 1:5: 95% = 49.0 s 1:6: 79% = 51.3 s 1:10: 47.5% = 58.4 s 1:20: 23.75% = 66.3 s 75 70 65 Seconds 60 55 50 45 2 12 25 50 75 100 % activity
6
Factor Activity assays
Patient sample: 1:5: 60.2 s 1:10: 67.2 s 1:20: 71.9 s 75 50% 24% x 2 = 48% 70 12.5% x 4 = 50% 65 Seconds 60 Average: 49% 55 50 45 2 12 25 50 75 100 % activity
7
Chromogenic factor VIII
Factor IXa, Ca, PL Factor Xa Factor X Patient’s factor VIII Factor Xa Peptide + pNA S-2765
8
Factor Assays: when and why
Prolonged PT and/or aPTT Mixing study correction vonWillebrands w/u (Factor VIII) Thrombophilia w/u Factors VIII, IX
9
Immediate and incubated @37oC for 1 hour
Mixing Studies Patient sample + Pooled normal plasma Immediate and for 1 hour PT/aPTT corrects PT/ aPTT does correct Factor Deficiency Inhibitor
10
Factor Activity assays
Patient sample: 1:5: 60.2 s 1:10: 64.4 s 1:20: 67.5 s 75 50% 37.5% x 2 = 75% 70 25% x 4 = 100% 65 Seconds 60 Average: 75% Poor agreement 55 50 45 2 12 25 50 75 100 % activity
11
Factor VIII Inhibitor assay Neat and pre-diluted samples with Buffer
Dil PPP + PNP + Factor VIII deficient plasma Activators Clot detection CaCl2 37oC
12
Factor Inhibitor Assay
Calibrator: PNP + Buffer 1:5:100% = 60s 1:10: 50% = 62s 1:20: 25% = 66s 1:40:12.5% = 71s 1:80: 6.25% = 75s 85 80 75 Seconds 70 65 60 55 2 12 25 50 75 100 % activity
13
Factor Inhibitor Assay
Patient sample 1:5:100% = 55 s 1:10: 50% = 61s 1:20: 25% = 66 s >100 % 85 84 x 2 = >100% 80 63 x 4 = >100% 75 Seconds 70 No inhibitor present 65 60 55 2 12 25 50 75 100 % activity
14
Factor Inhibitor Assay- Bethesda method
Patient sample Neat sample: = 80 s 1:5 pre: 50% = 61s 1:10 pre: 25% = 66 s <20 % 85 50% 80 75% 75 Seconds 70 65 60 55 2 12 25 50 75 100 % activity
15
% Residual Activity Bethesda units
100 80 0.3 75 0.4 70 0.5 65 0.6 60 0.7 55 0.9 50 1.0 45 1.2 40 1.3 35 1.5 30 1.7 25 2.0 20 2.3 15 2.7 10 3.3 A patient sample producing a residual factor activity of 50% is said to contain 1 Bethesda unit of inhibitor
16
Average : 4.5 B.U. Patient sample results
% Residual Activity Bethesda units 100 80 0.3 75 0.4 70 0.5 65 0.6 60 0.7 55 0.9 50 1.0 45 1.2 40 1.3 35 1.5 30 1.7 25 2.0 20 2.3 15 2.7 10 3.3 Patient sample results Neat sample: <20% residual factor VIII activity 1:5 pre: 50% residual activity 1 B.U 1:10 pre: 75% residual activity 0.4 B.U. x 5 = 5 B.U x 10 = 4 B.U. Average : 4.5 B.U.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.